Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

Conditions:   HIV;   HIV/AIDS;   HIV-1 Infection Interventions:   Drug: Pegylated Interferon alpha 2b (peg-IFN-α2b);   Drug: 3BNC117 + 10-1074 Sponsors:   Luis Montaner;   University of Pennsylvania;   Philadelphia Fight;   Rockefeller University;   Merck Sharp & Dohme Corp.;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials